A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson’s disease patients.
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Dysfunction of proteasomal protein degradation is involved in neurodegeneration in Parkinson's disease (PD). Recently we identified the regulatory proteasomal subunit S6 ATPase as a novel interactor of synphilin-1, which is a substrate of the ubiquitin-ligase Parkin (PARK2) and an interacting protein of alpha-synuclein (PARK1). To further investigate a potential role in the pathogenesis of PD, we performed a detailed mutation analysis of the S6 ATPase gene in a large sample of 486 German sporadic and familial PD patients. Direct sequencing revealed two novel intronic variants. An insertion/deletion variant in intron 5 of the S6 ATPase gene was more frequent in patients compared to controls. Moreover, this variant was significantly more frequent in early-onset compared to late-onset PD patients. The identification of a genetic link between a regulatory proteasomal subunit and PD further underscores the relevance of disturbed protein degradation in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, Rpt3 mutations have been described in patients with Parkinson’s disease (Wahl et al., 2008).”
From Inducible Rpt3, a Proteasome Component, Knockout in Adult Skeletal Muscle Results in Muscle Atrophy (2020) · cites this paper as Wahl et al., 2008
Citations
Cites
GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism
Raymond, M., & Rousset, F. (1995) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a111573 · Cited by 15,397
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Subsequently alpha-synuclein was recognized as the major component of Lewy bodies not only in brains of rare mutation carriers, but also in brains of common idiopathic PD patients ( Spillantini et al. 1997 ).”
BackgroundMutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · cited 1×
“These proteins are critically related to the ubiquitin-mediated protein degradation pathway and are mutated in familial forms of PD ( Kitada et al. 1998; Leroy et al. 1998).”
BackgroundSelf-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608 · cited 2×
“The 26S proteasome is a multicatalytic protease complex that is critically involved in efficient removal of misfolded and regulatory proteins whose accumulation is detrimental to neuronal cells ( Voges et al. 1999 ).”
BackgroundThe ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
Ozelius, L. J., Hewett, J. W., Page, C. E., Bressman, S. B., Kramer, P. L., Shalish, C., de Leon, D., Brin, M. F., Raymond, D., Corey, D. P., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-40 · Cited by 1,007 · cited 1×
“The torsin A gene that is mutated in most cases of early onset dystonia (DYT1) encodes an AAA ATPAse as well ( Ozelius et al. 1997 ).”
BackgroundProteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Hazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., Davoine, C.-S., Cruaud, C., Dürr, A., Wincker, P., et al. (1999) · Nature Genetics · doi:10.1038/15472 · Cited by 634
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi215 · Cited by 568
Self-citationHLA and Disease 1982 ‐ A Survey
Svejgaard, A., Plartz, P., & Ryder, L. P. (1983) · Immunological Reviews · doi:10.1111/j.1600-065x.1983.tb00715.x · Cited by 543 · cited 1×
“Further statistical analysis [Chi square (CS), odds ratio (OR)] was performed as described previously ( Svejgaard et al. 1983 ).”
MethodCollaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
Giasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 507 · cited 1×
“... of genes involved in rare familial forms of Parkinson’s disease (PD) gave the first insight into protein misfolding and subsequent aggregation as mechanisms involved in neurodegeneration in PD. Mutations in the SNCA gene encoding alpha-synuclein cause autosomal dominantly inherited familial PD. The respective muta…”
BackgroundPickart, C. M. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01681-9 · Cited by 454 · cited 1×
“The formation of polyubiquitin chains is a prerequisite for recognition of the respective protein by the 26S proteasome ( Pickart 2000 ).”
BackgroundA proteasomal ATPase subunit recognizes the polyubiquitin degradation signal
Lam, Y. A., Lawson, T. G., Velayutham, M., Zweier, J. L., & Pickart, C. M. (2002) · Nature · doi:10.1038/416763a · Cited by 446 · cited 1×
“Degradation of misfolded proteins by the 20S catalytic core of the proteasome is ATP dependent and requires unfolding and translocation of the substrates by the respective ATPase subunits of the 19S particle including S6 ATPase (Larsen and Finley 1997; Wilkinson et al. 2000; Lam et al. 2002 ).”
BackgroundSnyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420 · cited 1×
“Recently, alpha-synuclein protein which aggregates in affected brain regions of PD patients was found to be a novel interactor of the proteasomal subunit S6 0 ATPase (tbp1; Snyder et al. 2003 ).”
BackgroundUCHL1 is a Parkinson's disease susceptibility gene
Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20017 · Cited by 262
Self-citationDoss-Pepe, E. W., Stenroos, E. S., Johnson, W. G., & Madura, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6469-6483.2003 · Cited by 237 · cited 1×
“Direct interactions of disease-causing proteins with components of the 19S particle have been described for several neurodegenerative disorders including spinocerebellar ataxia (SCA) 3 and 7, respectively (Matilla et al. 2001; Doss-Pepe et al. 2003 ).”
BackgroundParkin mutations and susceptibility alleles in late‐onset Parkinson's disease
Oliveira, S. A., Scott, W. K., Martin, E. R., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10524 · Cited by 214
Protein Translocation Channels in the Proteasome and Other Proteases
Larsen, C. N., & Finley, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80427-4 · Cited by 164 · cited 1×
“Degradation of misfolded proteins by the 20S catalytic core of the proteasome is ATP dependent and requires unfolding and translocation of the substrates by the respective ATPase subunits of the 19S particle including S6 ATPase ( Larsen and Finley 1997; Wilkinson et al. 2000; Lam et al. 2002).”
BackgroundMarx, F. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg134 · Cited by 145
Wilkinson, C. R. M., Ferrell, K., Penney, M., Wallace, M., Dubiel, W., & Gordon, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15182 · Cited by 81 · cited 1×
“Degradation of misfolded proteins by the 20S catalytic core of the proteasome is ATP dependent and requires unfolding and translocation of the substrates by the respective ATPase subunits of the 19S particle including S6 ATPase (Larsen and Finley 1997; Wilkinson et al. 2000; Lam et al. 2002).”
BackgroundAlpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients
Berg, D., Niwar, M., Maaß, S., Zimprich, A. A., Möller, J. C., Wüllner, U., Schmitz‐Hübsch, T., Klein, C., Tan, E., Schöls, L. J., et al. (2005) · Movement Disorders · doi:10.1002/mds.20504 · Cited by 75
Self-citationParkinson's disease: one biochemical pathway to fit all genes?
Krüger, R., Eberhardt, O., Rieß, O., Schulz, J. B., & Rieß, O. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02333-x · Cited by 71
Self-citationLi, Z., Arnaud, L., Rockwell, P., & Figueiredo‐Pereira, M. E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02456.x · Cited by 59
Targeted expression of dominant negative proteasome mutants in drosophila melanogaster
Belote, J. M., & Fortier, E. (2002) · genesis · doi:10.1002/gene.10131 · Cited by 57
Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex
Matilla, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2821 · Cited by 53 · cited 1×
“Direct interactions of disease-causing proteins with components of the 19S particle have been described for several neurodegenerative disorders including spinocerebellar ataxia (SCA) 3 and 7, respectively ( Matilla et al. 2001; Doss-Pepe et al. 2003).”
BackgroundMarx, F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6734com · Cited by 52
Self-citationParkinson's disease: progression and mortality in the L-DOPA era.
Rocco, A. D., Molinari, S. P., Kollmeier, B., & Yahr, M. D. (1996) · PubMed · Cited by 52
Rpn5 Is a Conserved Proteasome Subunit and Required for Proper Proteasome Localization and Assembly
Yen, H.-C. S., Espiritu, C., & Chang, E. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302093200 · Cited by 42 · cited 1×
“Moreover, interference with 19S proteasomal function by manipulating the regulatory subunit Rpn5, a component of the lid, resulted in severe growth defects and accumulation of polyubiquitinated proteins in yeast ( Yen et al. 2003 ).”
Background
Cited by
The role of protein clearance mechanisms in organismal ageing and age-related diseases
Vilchez, D., Saez, I., & Dillin, A. (2014) · Nature Communications · doi:10.1038/ncomms6659 · Cited by 689
Regulation of proteasome activity in health and disease
Schmidt, M., & Finley, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.012 · Cited by 464
“onset [175].”
The Mechanistic Links Between Proteasome Activity, Aging and Agerelated Diseases
Saez, I., & Vilchez, D. (2014) · Current Genomics · doi:10.2174/138920291501140306113344 · Cited by 325
“In addition, variations in the gene PSMC4/Rpt3 correlate with the age of PD onset in patients [131].”
BackgroundThe Ubiquitin–Proteasome System in Immune Cells
Çetin, G., Klafack, S., Studencka-Turski, M., Krüger, E., & Ebstein, F. (2021) · Biomolecules · doi:10.3390/biom11010060 · Cited by 209
Tashiro, Y., Urushitani, M., Inoue, H., Koike, M., Uchiyama, Y., Komatsu, M., Tanaka, K., Yamazaki, M., Abe, M., Misawa, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417600 · Cited by 194
“Rpt3 is a subunit of 26S proteasome of which mutations are reported in Parkinson disease patients (34), and knock-out of mice Rpt3 gene results in early-embryonic lethality (35).”
Background
Metadata
- Authors
- Wahl, C., Kautzmann, S., Krebiehl, G., Strauss, K., Woitalla, D., Müller, T., Bauer, P., Riess, O., & Krüger, R.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Ruhr University Bochum (DE)
- St. Joseph-Krankenhaus (DE)
- University of Tübingen (DE)
- Corresponding author
- Krüger, Rejko
- Venue
- Journal of Neural Transmission
- Published
- 2008-04-30
- Volume
- 115
- Issue
- 8
- Pages
- 1141-1148
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2075222422
- Cited by
- 22
- References
- 31
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- green
- orbilu.uni.lu
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, proteasome, protein degradation, synphilin-1, Parkin, alpha-synuclein, intronic variants, insertion-deletion variants, early-onset Parkinson's disease, familial Parkinson's disease, genetic susceptibility, German patients
- MeSH terms
- ATPases Associated with Diverse Cellular Activities, Adenosine Triphosphatases, Aged, Alleles, Carrier Proteins, Chromatography, High Pressure Liquid, DNA Mutational Analysis, Female, Genotype, Germany, Humans, Introns, Male, Middle Aged, Nerve Tissue Proteins, Parkinson Disease, Protein Denaturation, Polymorphism, Restriction Fragment Length, RNA, Messenger, DNA, Complementary, Reverse Transcriptase Polymerase Chain Reaction, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.